Intestinimonas remains elevated in aged SAMP8 mice and links to opposite CD4⁺/CD8⁺ T‑cell ratio shifts in brain versus spleen

The Question

Researchers have long recognized that the gut‑brain axis shapes neural health, yet how age‑related shifts in the microbiome influence immune dynamics within the brain remains poorly defined.

The Experiment

Lead author Peschke and colleagues at the Institute of Medical Microbiology and Hygiene and the Research Center for Immunotherapy (FZI) conducted a comparative study in two mouse strains: senescence‑accelerated SAMP8 and senescence‑resistant SAMR1. Using a culture‑dependent plating approach together with 16S rRNA gene sequencing, they profiled fecal microbiota. Parallel flow cytometry characterized CD4⁺ and CD8⁺ T‑cell phenotypes in brain and splenic leukocytes. Mice were examined at a young adult stage and again at an aged stage; both sexes were included. The abstract does not disclose the exact number of animals per group.

What They Found

Microbial diversity varied by strain regardless of age, and several genera differed between young SAMP8 and SAMR1 mice. Notably, the genus Intestinimonas stayed elevated in aged SAMP8 mice while declining in SAMR1 controls. In the brain, SAMP8 mice displayed a higher CD4⁺/CD8⁺ ratio and an increased frequency of pro‑inflammatory cytokine‑producing CD4⁺ T cells compared with SAMR1. Conversely, spleens of SAMP8 mice showed a lower CD4⁺/CD8⁺ ratio; only aged SAMP8 spleens exhibited heightened T‑cell activation (effector/naïve ratios) and more cytokine‑producing CD4⁺ and CD8⁺ cells. Correlation analysis linked nine bacterial genera to immune cell frequencies, with CD8⁺ T‑cell metrics correlating more strongly with microbiota composition than strain, age, or sex.

Why It Matters

The findings tie gut microbial composition to age‑dependent remodeling of brain‑resident immunity. An elevated CD4⁺/CD8⁺ ratio and pro‑inflammatory T‑cell profile are hallmarks of neuroinflammation, a driver of cognitive decline. Persistent enrichment of Intestinimonas may skew systemic T‑cell trafficking, producing opposite shifts in the brain versus spleen. This suggests that specific microbial taxa could modulate peripheral‑to‑central immune signaling, potentially accelerating brain aging.

Study Limitations

• Absence of a reported sample size hampers assessment of statistical power.


• Results derive from a single accelerated‑aging mouse model; translational relevance to human aging is uncertain.


• Cross‑sectional design captures only two age points, limiting insight into dynamic temporal changes.

Practical Application

It is too early to translate these observations into a personal protocol. Human studies that longitudinally track gut microbiota, brain‑resident T‑cell phenotypes, and cognitive outcomes are required. Interventional trials testing whether modulation of Intestinimonas (e.g., via diet, probiotics, or antibiotics) can reshape CD4⁺/CD8⁺ ratios in the brain would be a logical next step. Until such data exist, no specific dosage, timing, or supplementation recommendation can be justified.

Disclaimer: This article is for informational and educational purposes only. The information presented does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before modifying your diet, supplementation, or exercise routines. The scientific studies cited reflect the state of knowledge at their publication date and may be subject to revision.